As Per the Report, the Size of the Middle East & Africa Digital Breast Tomosynthesis (DBT) Equipment Market is valued at USD 116.30 Million in 2023 and is estimated to grow at a CAGR of 11.6%, reaching USD 201.34 million by 2028 during the forecast period 2023 to 2028.
The increasing prevalence of breast cancer will drive market growth during the projected period. According to Breastcancer.org, 268,600 new cases of invasive breast cancer in women were diagnosed in 2019, along with 62,900 new cases of non-invasive breast cancer. According to the World Health Organization (WHO), breast cancer is the most common type of cancer in women across the globe, with around 2.16 million women suffering from breast cancer each year, with the highest number of deaths among women due to cancer. In 2019, approximately 15% of all cancer deaths among women were due to breast cancer.
Owing to these high numbers, various international and local government authorities are taking initiatives to promote breast cancer awareness and treatment options. Increased breast cancer screening and the presence of favorable reimbursement policies are other factors that are driving the market. In addition, continuous research and development with innovative technological advantages will push the market positively.
Patients are exposed to higher radiation levels during a procedure than 2D mammography. Hence, companies aim to reduce this radiation exposure, especially for re-mission cancer patients. In addition, advancement in other diagnostics equipment and wide adoption of equipment is expected to provide lucrative growth opportunities for this market.
Across the MEA region, the purchase of Debt equipment is costly and not affordable by many hospitals. This initial high investment with a lack of reimbursement policies reduces market growth, especially in under-developed regions. Other factors like the lack of availability of devices, poor healthcare infrastructure, and skilled labor to perform the procedure will harm the MEA digital breast tomosynthesis Debt equipment market in the coming years.
This research report on the Middle East & Africa Digital Breast Tomosynthesis (DBT) Equipment Market has been segmented and sub-segmented into the following categories.
By Product:
By End User:
By Country:
Geographically, the Middle East & Africa Digital Breast Tomosynthesis (DBT) Equipment Market is the largest market share in terms of revenue due to the high purchasing power in this region.
The UAE Digital Breast Tomosynthesis (DBT) Equipment Market is predicted to grow at a decent CAGR owing to the higher incidence, and this region has poor healthcare infrastructure, which reduces the market growth rate. On the other hand, this region also has adequate resources to fund various aspects of breast cancer; this will provide many growth opportunities for the studied market.
The Saudi Arabia Digital Breast Tomosynthesis (DBT) Equipment Market is the largest market share in the MEA region due to the high incidence of breast cancer and the presence of improved healthcare infrastructure, senior population, and increased disposable income.
The South African Digital Breast Tomosynthesis (DBT) Equipment Market registered at a slow growth rate due to the high number of breast cancer cases in this region. And it currently has the highest age-standardized breast cancer death rate globally, with the highest incidence rates recorded during the forecast period.
KEY MARKET PLAYERS
Key Market Companies dominating the Middle East & Africa Digital Breast Tomosynthesis (Debt) Equipment Market Profiled in the Report are Hologic Inc., Fujifilm Corporation, Siemens Healthineers, GE Healthcare, Internazionale Medico Scientifica S.r.l., and Planmed OY.,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region